Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | glutamine | 182 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | glutamine | 311 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 314 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | glutamine | 412 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
GC POSITIVE ION MODE | glutamine | 495 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 516 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
GC POSITIVE ION MODE | glutamine | 517 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | glutamine | 533 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
GC POSITIVE ION MODE | glutamine | 558 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | glutamine | 577 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 665 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
GC POSITIVE ION MODE | glutamine | 693 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 752 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | glutamine | 813 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | glutamine | 824 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 825 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 832 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 916 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 930 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | glutamine | 937 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | glutamine | 976 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 995 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | glutamine | 1195 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
GC POSITIVE ION MODE | glutamine | 1289 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
GC POSITIVE ION MODE | glutamine | 1317 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | glutamine | 1477 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 1581 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
GC POSITIVE ION MODE | glutamine | 1720 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
GC POSITIVE ION MODE | glutamine | 1738 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 1739 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | glutamine | 1742 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 1822 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | glutamine | 1961 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | glutamine | 1989 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | glutamine | 2069 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 2238 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
GC POSITIVE ION MODE | glutamine | 2254 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
GC POSITIVE ION MODE | glutamine | 2281 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
GC POSITIVE ION MODE | glutamine | 2551 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | glutamine | 2677 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
GC POSITIVE ION MODE | glutamine | 2754 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | glutamine | 2769 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | glutamine | 2795 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | glutamine | 2933 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | glutamine | 3170 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
GC POSITIVE ION MODE | glutamine | 3172 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | glutamine | 3282 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
GC POSITIVE ION MODE | glutamine | 3464 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
GC POSITIVE ION MODE | glutamine | 3501 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | glutamine | 3709 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
GC POSITIVE ION MODE | glutamine | 3870 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | glutamine | 4070 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
GC POSITIVE ION MODE | glutamine | 4215 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | glutamine | 4912 | Counts | NA | NA | NA | - |
GC POSITIVE ION MODE | glutamine | 4922 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
GC POSITIVE ION MODE | glutamine | 5720 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
GC POSITIVE ION MODE | glutamine | 10919 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |
GC POSITIVE ION MODE | glutamine | 85317 | Counts | NA | NA | NA | - |